Journal article
Gene Therapy Progress and Prospects : Development of improved lentiviral and retroviral vectors - design, biosafety, and production
Gene therapy, Vol.12(14), pp.1089-1098
2005
DOI: 10.1038/sj.gt.3302570
PMID: 16003340
Abstract
Replication defective vectors derived from simple retroviruses or the more complex genomes of lentiviruses continue to offer the advantages of long-term expression, cell and tissue specific tropism, and large packaging capacity for the delivery of therapeutic genes. The occurrence of adverse events caused by insertional mutagenesis in three patients in a gene therapy trial for X-linked SCID emphasizes the potential for problems in translating this approach to the clinic. Several genome-wide studies of retroviral integration are now providing novel insights into the integration site preferences of different vector classes. We review recent developments in vector design, integration, biosafety, and production.
Details
- Title: Subtitle
- Gene Therapy Progress and Prospects : Development of improved lentiviral and retroviral vectors - design, biosafety, and production
- Creators
- P. L SINN - Program in Gene Therapy, Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA, United StatesS. L SAUTER - Virogenics Inc, San Diego, CA, United StatesP. B MCCRAY - Program in Gene Therapy, Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA, United States
- Resource Type
- Journal article
- Publication Details
- Gene therapy, Vol.12(14), pp.1089-1098
- Publisher
- Nature Publishing Group
- DOI
- 10.1038/sj.gt.3302570
- PMID
- 16003340
- ISSN
- 0969-7128
- eISSN
- 1476-5462
- Language
- English
- Date published
- 2005
- Academic Unit
- Microbiology and Immunology; Pulmonary Medicine; Stead Family Department of Pediatrics; Internal Medicine
- Record Identifier
- 9984093365302771
Metrics
16 Record Views